Sofinnova Investments, Inc. Kiniksa Pharmaceuticals, Ltd. Transaction History

Sofinnova Investments, Inc.

  • $1.06 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$14.8 - $21.15 $4.09 Million - $5.85 Million
-276,628 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$15.21 - $25.53 $8.11 Million - $13.6 Million
-533,175 Reduced 65.84%
276,628 $4.24 Million
Q2 2020

Aug 13, 2020
SELL
$15.08 - $26.0 $1.7 Million - $2.94 Million
-112,897 Reduced 12.24%
809,803 $20.6 Million
Q2 2018

Aug 14, 2018
BUY
$16.73 - $20.35 $15.4 Million - $18.8 Million
922,700 New
922,700 $16 Million

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $687M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email